| 1 |
31884929 | Mechanisms and Characteristics of Sulfonylureas and Glinides. | 2020 |
4 |
| 2 |
30621663 | Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report. | 2019 Jan 8 |
1 |
| 3 |
25560470 | Pharmacogenomics of glinides. | 2015 Jan |
2 |
| 4 |
25810423 | Add-on treatment with mitiglinide improves residual postprandial hyperglycemia in type 2 diabetic patients receiving the combination therapy with insulin glargine and sitagliptin. | 2015 Apr |
2 |
| 5 |
26336611 | Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study. | 2015 |
1 |
| 6 |
23797928 | Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus. | 2013 Aug |
1 |
| 7 |
23992284 | Mitiglinide for type 2 diabetes treatment. | 2013 Oct |
1 |
| 8 |
24215809 | The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study. | 2013 Nov 11 |
1 |
| 9 |
22994875 | Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus. | 2012 Nov |
1 |
| 10 |
20841518 | Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus. | 2010 Oct |
1 |
| 11 |
17185877 | Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study. | 2007 Feb |
1 |
| 12 |
16543674 | Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus. | 2006 Feb |
3 |
| 13 |
15467258 | [Pharmacological and clinical profile of mitiglinide calcium hydrate (Glufast), a new insulinotropic agent with rapid onset]. | 2004 Oct |
2 |
| 14 |
10509738 | Binding of tritiated S21403 to an artificial phospholipid bilayer. | 1999 Mar |
1 |